Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a clinical-stage biotech, is pioneering the use of artificial intelligence and ...

BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Tonix Pharmaceuticals has secured a presentation slot at the prestigious BIO CEO & Investor Conference, which can enhance visibility and investor interest in the company. The company’s product ...

Bluebird bio has rebranded to Genetix Biotherapeutics, marking a new chapter for the company that was once a frontrunner in ...

SOMERVILLE, Mass., September 18, 2025--bluebird bio, Inc. today announced it has rebranded as Genetix Biotherapeutics Inc., returning to its foundational roots. Genetix, now strengthened both ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

Infinity Bio takes a business-to-business approach to pharmaceuticals. Here's more on the company and its growth. A Johns Hopkins University spinout has opened a 9,000-square-foot lab in East ...

BERWYN, Pa.--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic ...

Kala Pharmaceuticals ( ($KALA) ) has provided an update. On September 16, 2025, the Board of Directors of KALA BIO, Inc. set December 11, 2025, as ...

Detailed price information for Cyclacel Pharmaceuti (CYCC-Q) from The Globe and Mail including charting and trades.